Maurizio Infante

Dr. Maurizio Valentino Infante's clinical practice encompasses the full range of thoracic surgical oncology procedures, including VATS-surgery and RATS for lung cancer, thymoma and myasthenia gravis, malignant pleural mesothelioma, infectious lung disease, esophageal cancer, and chest-wall tumors, deformities, and trauma.

In the past, he was involved in lung cancer chemoprevention and esophageal surgery and he developed a conservative approach to esophageal suture-line leaks that proved to be successful and was adopted as standard divisional practice at the National Cancer Institute of Milan.

In 2001 he launched the DANTE trial, a randomized trial of LDCT screening for lung cancer. Formerly Scientific Advisor of the Italian VATS group, promoting major lung resection by VATS for lung cancer in Italy (www.vatsgroup.it). Member of The IASLC staging and Prognostic Factors Committee as of 2018

Infante's current interest areas include lung cancer, malignant pleural mesothelioma, inflammation and immunity, minimally invasive VATS and RATS surgery, nodule management, VATS-segmentectomy, thymoma and myasthenia gravis, and oligometastatic NSCLC.